| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.006 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.007 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |